The Pharmaceutical Benefits Advisory Committee recommended listing new medicines for endometriosis, breast cancer, and a range of other conditions and expanding the listing of others.
'An important first step to achieving reimbursed access for eligible patients in Australia'
April 28, 2024 Latest NewsBioPharmaLatest Video
New Stories
-
The 2024-25 Budget Review Podcast
May 15, 2024 - - Podcast -
The Budget should leave people in no doubt that more announcements are coming
May 15, 2024 - - Latest News -
Stakeholder response to the Albanese Government's 2024-25 Budget
May 15, 2024 - - Latest News -
Budget maintains a single non-financial performance indicator for the PBS
May 15, 2024 - - Latest News -
Patients secure a cost-of-living win with all indications more change is coming
May 14, 2024 - - Latest News -
TGA seeks views on proposed medical device reform changes
May 14, 2024 - - Australian Biotech -
Race shares the resulsts of preclinical studies combining bisantrene with decitabine
May 14, 2024 - - Latest News